Mitessh Thakkar of mitesshthakkar.com told CNBC-TV18, "Let us go back to March 2015 when Sun Pharma was about Rs 1120-1130 levels and then we have seen a big correction. The stock has more than halved. Now it is showing some signs of a reversal, I hope it sustains this time. It has had some false dawns earlier as well but it looks like that this stock could now possibly get into a short to medium term uptrend, so you can buy more, keep a stop loss below levels of Rs 495-500, that being the support zone."
"On the upside, I think targets could be roughly around Rs 625. In case we get past Rs 625, we can even look at Rs 700-710 happening but that is something which I will possibly know in time to come by. For the time being I would suggest Rs 625 should be the target and try to add it around Rs 520-530 zones on a bad day when there is some kind of USFDA announcement or something like that."
"Lot of these beaten down stocks specially the infra names – JP Associates and GMR Infra have at least reversed from their lows at which they were trading at about a year and a half back. So, in that sense there is some kind of a medium term upmove going on."
"I would suggest holding on to GMR Infra, in case price is closer to about Rs 24-24.5 which is my target for this entire upmove which could happen in the next few months, I think that is a good level to exit and forget about it. I don’t think there is a big change happening over here. However after having fallen from Rs 100 plus to as low as Rs 10, I think it is just a slightly bigger bounce back," he said.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!